Living with and treating ATTR amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Strategies to promote communication among the different healthcare providers you need to work with to treat ATTR-CM.

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.